The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Enterprise-level AI screening for oncology trials: Improving patient identification with OncoLLM.
 
Grace Westerman
No Relationships to Disclose
 
Claire Verhagen
No Relationships to Disclose
 
Haley Heaviland
No Relationships to Disclose
 
Erin Lynch
No Relationships to Disclose
 
Olivia Brandenburg
Employment - Triomics
 
Jennifer Patton
Employment - Triomics
 
Regina Schwind
Employment - Tempus AI; Triomics
Stock and Other Ownership Interests - Tempus AI
Consulting or Advisory Role - Sus Clinicals Inc.
Patents, Royalties, Other Intellectual Property - Modeling Oncology On Demand “MOOD” [patent# US-20220186190-A1; pub June 16, 2022]
 
Ben George
Consulting or Advisory Role - AstraZeneca; Boston Scientific; Bristol-Myers Squibb; Foundation Medicine; Ipsen; Roche/Genentech; Taiho Pharmaceutical; Tempus
Speakers' Bureau - AstraZeneca; Taiho Oncology
Research Funding - CARsgen Therapeutics (Inst); GlycoNex (Inst); Helix BioPharma (Inst); Helix BioPharma (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Roche (Inst); Roche/Genentech (Inst); Sirnaomics (Inst); Taiho Pharmaceutical (Inst); Toray Industries (Inst); Transcenta (Inst); Trishula Therapeutics (Inst); Tvardi Therapeutics (Inst)
 
Anai Kothari
Research Funding - Triomics